Inventor · disambiguated record
Larry H. Matherly
Also filed as: MATHERLY LARRY H
14 granted patents·5 pending applications·12 citations·filing 2007–2022
87Inventor score
Top patents by PatentIndex Score
19 records- 0189US8258143B2Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancerGANGJEE ALEEM·Filed 2007·Granted Sep 4, 2012·5 cites·25 claims
- 0288US8552014B2Methods of using selective chemotherapeutic agents for targeting tumor cellsGANGJEE ALEEM·Filed 2012·Granted Oct 8, 2013·4 cites·25 claims
- 0384US8952019B2Methods of using selective chemotherapeutic agents for targeting tumor cellsGANGJEE ALEEM·Filed 2013·Granted Feb 10, 2015·2 cites·25 claims
- 0474US2023091810A1First-in-class of shmt2 and mthfd2 inhibitors as antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2022·Application pending·0 cites
- 0571US10611767B2Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the sameUNIV HOLY GHOST DUQUESNE·Filed 2018·Granted Apr 7, 2020·0 cites·7 claims
- 0670US11384084B2First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Jul 12, 2022·0 cites·11 claims
- 0770US11053252B2Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the sameUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Jul 6, 2021·0 cites·4 claims
- 0870US10793573B2First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2018·Granted Oct 6, 2020·0 cites·1 claims
- 0969US9481678B2Substituted pyrrolo[2,3-D]dipyrimidines for selectively targeting tumor cells with FR-alpha and FR-beta type receptorsDUQUESNE UNIV OF THE HOLY GHOST·Filed 2015·Granted Nov 1, 2016·1 cites·2 claims
- 1066US8252804B2Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the sameGANGJEE ALEEM·Filed 2008·Granted Aug 28, 2012·0 cites·3 claims
- 1163US2019135816A1Substituted pyrimidine compounds and methods of use and manufactureGANGJEE ALEEM·Filed 2018·Application pending·0 cites
- 1263US2025049799A1Targeted Therapy of Pyrrolo[2,3-D]Pyrimidine Antifolates in a Syngeneic Mouse Model of High Grade Serous Ovarian CancerUNIV HOLY GHOST DUQUESNE·Filed 2022·Application pending·0 cites
- 1362US10167287B2Substituted pyrimidine compounds and methods of use and manufactureUNIV HOLY GHOST DUQUESNE·Filed 2017·Granted Jan 1, 2019·0 cites·1 claims
- 1460US10000498B2Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the sameUNIV HOLY GHOST DUQUESNE·Filed 2016·Granted Jun 19, 2018·0 cites·16 claims
- 1560US9650384B2Substituted pyrimidine compounds and methods of use and manufactureUNIV HOLY GHOST DUQUESNE·Filed 2015·Granted May 16, 2017·0 cites·4 claims
- 1660US9511069B2Selective proton coupled folate transporter and folate receptor, and GRAFTase inhibitor compounds and methods of using the sameGANGJEE ALEEM·Filed 2012·Granted Dec 6, 2016·0 cites·17 claims
- 1754US9446045B2Methods of using selective chemotherapeutic agents for targeting tumor cellsGANGJEE ALEEM·Filed 2015·Granted Sep 20, 2016·0 cites·25 claims
- 1845US2017015672A1Substituted pyrrolo[2,3-d]pyrimidines for selectively targeting tumor cells with fr-alpha and fr-beta type receptorsDUQUESNE UNIV OF THE HOLY GHOST·Filed 2016·Application pending·0 cites
- 1944US2011082158A1Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the sameGANGJEE ALEEM·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Larry H. Matherly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →